Non-sensorimotor symptoms in chronic inflammatory demyelinating polyneuropathy. [PDF]
Klostermann F, Steiner OL.
europepmc +1 more source
Unraveling Endocannabinoid Signaling Pathways in Cisplatin‐Induced Ototoxicity
We performed a comprehensive molecular profiling of the endocannabinoid (eCB) system (ECS) in an auditory Hair cell (HC)‐like cell line (1). Afterwards, we developed suitable in vitro and in vivo models of cisplatin‐induced ototoxicity where we identified distinct components of the ECS (CB2R, DAGLβ and ABHD6) as molecular targets of the drug (2 ...
Sakthimala Palaniappan +12 more
wiley +1 more source
Polyneuropathy is characterized by simultaneous bilateral symmetrical involvement of peripheral nerves. Clinical features in fully-developed cases are paresthesias, irregular 'glove and stocking' cutaneous sensory loss, loss of deep sensations, weakness of distal muscles of extremities, and absent deep tendon reflexes.
openaire +1 more source
Correction: Development of a PROM set for patients with Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP): study protocol. [PDF]
Pelouto F +3 more
europepmc +1 more source
West Nile Virus as a Trigger for Acute Inflammatory Demyelinating Polyneuropathy: Exploring Intravenous Immunoglobulin (IVIG) Efficacy and Disease Variability. [PDF]
Howard MD, Baman J, Bhutta R.
europepmc +1 more source
Clinical and electrophysiological study of polyneuropathy in patients with multiple sclerosis. [PDF]
Flintere-Flinte A +7 more
europepmc +1 more source
Diphtheria Presenting With Cranial Neuropathy: The Patch Unseen. [PDF]
Ghosh S +4 more
europepmc +1 more source
Association Between Metabolic Syndrome Components and Polyneuropathy in an Obese Population.
B. Callaghan +8 more
semanticscholar +1 more source
Efficacy and safety of patisiran for the treatment of acquired amyloid polyneuropathy in domino liver transplant recipients. [PDF]
Nedkova-Hristova V +9 more
europepmc +1 more source

